MedX Health 2025 YEAR REVIEW
Businesswire·2025-12-15 11:00

Core Insights - MedX Health Corp. is a data-driven health analytics company specializing in skin health data through proprietary technologies and regulatory compliance [1][16] - The company is preparing for a large-scale rollout of its technology platform in 2026 after significant investments in 2025 [3][14] Operational and Strategic Update - In fiscal 2025, MedX invested over CAD$2 million in technology development, intellectual property, and operational infrastructure [3] - The company made targeted hires in executive leadership and technology to enhance long-term commercial readiness [3] DermSecure® and SIAscopy® - MedX expanded its DermSecure® platform, now featuring approximately 85,000 clinically reviewed skin images, enhancing its data asset for AI-driven skin analysis [4] - The SIAscopy® technology remains the industry standard for non-invasive skin analysis, utilized by over 26 Contract Research Organizations (CROs) [10] Leadership Changes - In Q3 2025, MedX appointed a new CEO and its first CTO to consolidate technology development responsibilities [5] - A Chief Operating Officer was also appointed to enhance operational capabilities following a commercial agreement with Health Partners Group [6] Photobiomodulation Division - The Photobiomodulation division saw steady revenue growth in 2025, supported by product line expansion and regulatory compliance [7] - New laser products, including the Oralase dental laser and LumaVet veterinary system, were introduced to broaden market reach [8][9] CRO and Beauty & Aesthetics Activities - MedX's technology and services were provided to major global beauty brands, enhancing its CRO offerings through integrated imaging and data assets [10][11] - The company was released from an exclusive licensing agreement with Procter & Gamble, allowing it to pursue new commercial opportunities [12] Future Outlook - The company views 2025 as a foundational year for platform development and operational readiness, positioning itself for expanded commercial activities in 2026 [14]